21_01_OutsourcedPharmaLive_SiteHeader


Welcome to Outsourced Pharma Live – An online interactive forum to discuss the most important topics and trends impacting drug development and manufacturing outsourcing, and working with CDMOs.

Throughout the year, our Chief Editor, Louis Garguilo, brings together industry experts to discuss how sponsor companies can tackle some of today's biggest challenges in managing your CDMOs. Our audience gets to ask and have answered their questions during the presentation. Each Outsourced Pharma Live session is archived, and can be accessed at any time by registered site users.

YOU'RE A VIRTUAL BIOTECH? THINK AGAIN.

WHAT COVID-19 VACCINES TEACH US ABOUT ALL TECH TRANSFERS

  • What COVID-19 Vaccines Teach Us About All Tech Transfers

    Are there “lessons learned” and “best practices” from the COVID-19 vaccine efforts you can apply to tech transfers of your own projects — be they small molecule, biologics, or cell and gene therapies? View the On-Demand version of OP-Virtual from our discussion on November 4, 2020 on what we’ve learned thus far, and how to “transfer” that knowledge to your projects.

HOW TO HIRE A NEW GENERATION OF BIOPHARMA WORKERS FOR AN OUTSOURCING MODEL

  • How to Hire A New Generation Of Biopharma Workers For An Outsourcing Model

    Are you productively filling the open positions in your organization? New recruiting strategies are needed to attract and keep the best of a new generation of biopharma worker. In today’s highly outsourced model, technical experience must be matched carefully with “people skills,” and the right attitudes. Not to mention currently you have to do this in the middle of the COVID-19 pandemic. Some good news? We assembled a panel of experienced HR and external supply chain professionals, and the founder of three Centers for Biopharma Education and Training (CBET), to offer you their best practices, and answer your questions.

A NEW DECADE OF OUTSOURCING: WHAT CAN WE EXPECT?

  • A New Decade Of Outsourcing: What Can We Expect?

    Will the "Twenty-Twenties" be as exciting as they sound for our industry? For certain, nobody saw a coronavirus outbreak put outsourcing in such a public light. Outsourced Pharma hosted a live, virtual discussion in June 2020 focusing on four key areas: continuous manufacturing; cell and gene therapy influences; new sponsor-CDMO service models; and "Supply Chain 4.0."

MANAGING YOUR CDMOS - ADVICE FROM PROFESSIONALS WHO HAVE BEEN ON BOTH SIDES OF OUTSOURCING

PODCASTS WITH CHIEF EDITOR LOUIS GARGUILO

  • 029: The Effects Of Politics On Pharma

    According to Outsourced Pharma Chief Editor, Louis Garguilo, “politics has never played a bigger role in our (global) biopharma industry.” In this episode, we talk with Louis about three of his recent editorials that touch on this subject while also discussing the current IP debate in pharma and the origins of the coronavirus. 

  • 022: Not Your Same Old CDMOs

    2020 seems to be the year of the evolution of the atypical, newfangled CDMO. Pharma outsourcing editor Louis Garguilo talks about this trend and what makes these new models all the rage. 

  • 019: An Executive Order & PhRMA’s Response Spur A Debate

    Our guest, Outsourced Pharma Chief Editor Louis Garguilo, talks about the response from readers — and PhRMA — to his editorial, “Is PhRMA’s White House Rebuttal Acceptable?”

  • 017: Is Puerto Rico The Answer To U.S. Pharma Manufacturing?

    Louis Garguilo elaborates on his recent editorial regarding the immense opportunity that Puerto Rico offers —and has offered for years — pharma manufacturers looking to bring back operations to the states.

  • 010: Editorial Prompts Reader Feedback … And More Questions

    One provocative article about reducing our reliance on foreign sources for drug development leads to some strange feedback, which leads to some additional intriguing articles.

  • 006: The Pharma Supply Chain Is Holding Up…So Far

    What has the coronavirus outbreak taught us about the pharmaceutical supply chain? A lot, and some of it’s not good, according to our guest today, Louis Garguilo, Chief Editor of Outsourced Pharma.

louis-g-photo-edited

Louis Garguilo



Louis Garguilo is chief editor and conference chair for Outsourced Pharma, and a contributing editor to Life Science Leader magazine. He studied public relations and journalism at Syracuse University (and holds a Master’s in English), and has 30+ years of international experience in business communications and development positions. Louis spent a decade at a global pharmaceutical contract research, development and manufacturing organization; served under the governor of New York in the state’s economic development agency, as liaison to the pharmaceutical/biotechnology industry; was chief strategic officer for an e-learning software company; and spent most of the ‘80s and ‘90s in Japan as an educator, author, and business communications consultant, including for the Osaka Medical Center for Cancer and Cardiovascular Diseases.